Search

Your search keyword '"Moore, Ian N."' showing total 268 results

Search Constraints

Start Over You searched for: Author "Moore, Ian N." Remove constraint Author: "Moore, Ian N."
268 results on '"Moore, Ian N."'

Search Results

2. Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaques

4. Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine

8. mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates

9. Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primates

10. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses

11. Chlamydia evasion of neutrophil host defense results in NLRP3 dependent myeloid-mediated sterile inflammation through the purinergic P2X7 receptor

12. Pathogenesis and outcome of VA1 astrovirus infection in the human brain are defined by disruption of neural functions and imbalanced host immune responses

13. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

15. Investigation of the impact of clonal hematopoiesis on severity and pathophysiology of COVID-19 in rhesus macaques

16. Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters

17. Anophelessalivary apyrase regulates blood meal hemostasis and drives malaria parasite transmission

18. Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in non-human primates

19. TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndrome

21. Attenuated activation of pulmonary immune cells in mRNA-1273-vaccinated hamsters after SARS-CoV-2 infection

23. Figure S3 from Molecular Signature and Mechanisms of Hepatitis D Virus–Associated Hepatocellular Carcinoma

24. Data from Molecular Signature and Mechanisms of Hepatitis D Virus–Associated Hepatocellular Carcinoma

25. Human norovirus targets enteroendocrine epithelial cells in the small intestine

27. Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates.

28. Epithelial-intrinsic defects in TGFβR signaling drive local allergic inflammation manifesting as eosinophilic esophagitis

29. Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters

30. Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys

33. Imbalanced immune response and dysregulation of neural functions underline fatal opportunistic encephalitis caused by astrovirus

34. An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant replication in rhesus macaques

35. Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaques

38. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron

39. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron

40. Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine

41. Intranasal Pediatric Parainfluenza Virus-Vectored SARS-CoV-2 Vaccine Candidate Is Protective in Macaques

42. Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung

43. Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine–boosted nonhuman primates

44. Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway

45. An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant viral replication in rhesus macaques

46. Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

47. Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

48. Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates

49. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies

50. COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge

Catalog

Books, media, physical & digital resources